Comment on Mayock SP, Saim S, Fleming AB. In Vitro Drug Release After Crushing: Evaluation of Xtampza® ER and Other ER Opioid Formulations
Sign Up to like & getrecommendations! Published in 2018 at "Clinical Drug Investigation"
DOI: 10.1007/s40261-018-0663-z
Abstract: The publication by Mayock et al. [1] provides incomplete information that may leave your readership with a false sense of security regarding the expected performance and impact that the Xtampza ER formulation may have on… read more here.
Keywords: comment mayock; xtampza; study; drug ... See more keywords
Effect of physical manipulation on the oral pharmacokinetic profile of Xtampza® ER (oxycodone DETERx® formulation): A review of published studies.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of opioid management"
DOI: 10.5055/jom.2020.0559
Abstract: Opioids can be an effective treatment option for appropriate patients with chronic pain for whom nonpharmacological or nonopioid treatment does not provide adequate pain relief. However, extended-release (ER) opioid formulations, because of their high drug… read more here.
Keywords: oxycodone deterx; published studies; xtampza; xtampza oxycodone ... See more keywords